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Purpose: Evidence about the effect of maternal vitamin B12 supplementation during pregnancy on 31 
offspring’s vitamin B12 status is limited. The present study aimed to evaluate the impact of antenatal 32 
vitamin B complex supplementation on neonatal vitamin B12 status.  33 
Methods: In an ongoing cluster randomized controlled trial conducted in three rural counties in 34 
northwest China, pregnant women <20 week of gestation were randomized to three treatment groups: 35 
blank control, iron supplements, or vitamin B complex supplements. All women were administered 36 
folic acid supplements during the periconceptional period. In a sub-study, we collected cord blood 37 
samples of 331 participants from the control or vitamin B complex groups in the Xunyi county from 38 
Jan.2017 to Dec.2017. Plasma concentrations of folate, vitamin B12, and homocysteine were 39 
measured. Two-level linear mixed models were used to compare differences between groups.  40 
Results: Compared with newborns whose mothers were in the control group, newborns of the vitamin 41 
B complex-supplemented women had significantly higher cord plasma vitamin B12 concentrations (P 42 
= 0.001) and lower homocysteine concentrations (P = 0.033). There was no significant difference in 43 
cord plasma folate concentrations between groups (P > 0.05). 44 
Conclusions: Maternal vitamin B complex supplementation during pregnancy is effective in 45 
improving neonatal vitamin B12 status in rural northwest China. 46 
Keywords: Antenatal vitamin B complex supplementation; Newborns; Vitamin B12 status; Cluster 47 
randomized controlled trial; Rural northwest China 48 
 49 
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Introduction  51 
Vitamin B12, also known as cobalamin, is a water-soluble vitamin that is mainly acquired from 52 
animal-source foods such as meat, poultry, eggs, seafood, and dairy products [1]. Together with folate, 53 
vitamin B12 is involved in the synthesis of purines and pyrimidines as well as the methylation of DNA, 54 
RNA and protein [2]. To prevent the occurrence of neural tube defects, folic acid (FA) supplements 55 
are widely recommended for women planning to become pregnant [3] and mandatory FA fortification 56 
programs have been implemented in numerous countries [4]. Vitamin B12 deficiency is common 57 
among women of childbearing age in parts of the world, however, was less studies than folate [5]. In 58 
a population-based cross-sectional study in Shaanxi province of northwest China, we reported that 59 
the prevalence of vitamin B12 deficiency among rural women aged 10-49 years was 52.0% [6], which 60 
is comparable to that of South Asia [7-10]. Moreover, another survey in this region indicated that only 61 
16.8% of pregnant women took vitamin B12-containing supplements before conception or during 62 
pregnancy [11].  63 
Accumulating studies showed that suboptimal vitamin B12 concentrations during pregnancy is 64 
associated with neural tube defects [12], intrauterine growth retardation [13], as well as poor cognitive 65 
function [14] and high insulin resistance [15] in children. We hypothesized that antenatal vitamin B12 66 
supplementation may be a cost-effective and feasible strategy to improve offspring’s vitamin B12 67 
status and short-term and long-term health outcomes. To our knowledge, few clinical trials have 68 
explored the effect of maternal vitamin B12 supplementation on offspring’s biochemical indicators 69 
and most of them only focused on the South Asian populations [16-18].  70 
A cluster randomized controlled trial in rural northwest China have been conducted to assess the 71 
protective effect of micronutrient supplementation during pregnancy on congenital heart disease and 72 
other adverse birth outcomes. Using data from the large trial, the present study aimed to examine 73 
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whether vitamin B complex supplementation during pregnancy could be effective to affect neonatal 74 
folate, vitamin B12, and homocysteine (Hcy) concentrations.  75 
 76 
Methods 77 
Study design and participants 78 
This study was a biomarker sub-study of the ongoing cluster randomized controlled trial (registered 79 
at clinicaltrial.gov as NCT02537392) that aimed to investigate the effect of micronutrient 80 
supplementation during pregnancy on congenital heart disease and other adverse birth outcomes. This 81 
trial was conducted in three rural counties (Changwu, Bin and Xunyi) in northwest China since July 82 
2015. Women who were aged 15-49 years and have already been pregnant for less than 20 weeks 83 
were invited to participate in this trial. Exclusion criteria at recruitment included 1) use of 84 
supplements containing vitamin B complex or iron for more than two weeks, 2) having given birth to 85 
children with congenital heart disease or other birth defects, and 3) having serious illnesses. As 86 
pregnant women were administrated by township maternal and child health workers in northwest 87 
China, a cluster randomized design, with a township as the unit of randomization, was used to 88 
minimize the risk of contamination of the intervention. The township clusters were randomized to the 89 
control, iron, or vitamin B complex groups with a 1:1:1 ratio before enrolment. 90 
In accordance with the national policy for pregnant women in China, all women in this trial were 91 
provided daily 400 g FA supplements during pre-pregnancy and early pregnancy by County Health 92 
Commission [19]. Women in the control group didn’t receive any other micronutrient supplements. 93 
Women in the iron group received a tablet (Ferrous sulfate/tablet; Jinan Yongning Pharmaceutical 94 
Co., Ltd) containing 60 mg of iron, and those in the vitamin B complex group received supplements 95 
(Weikangfu/tablet; Sino-American Shanghai Squibb Pharmaceuticals Ltd) containing 2 mg of 96 
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vitamin B1, 2 mg of vitamin B2, 2 mg of vitamin B6, 2 g of vitamin B12, 5 mg of calcium pantothenate, 97 
15 mg of nicotinamide (per tablet). Participants in both the iron and vitamin B complex groups were 98 
instructed to take one tablet daily from enrolment to delivery. All micronutrient supplements were 99 
commercially available during the period of this trial. 100 
Pregnant women who were enrolled in the Xunyi county from Jan.2017 to Dec.2017 were further 101 
invited to participate in the biomarker sub-study. Women were excluded from the sub-study if they 102 
decided to deliver outside the Xunyi county or had twin births. Since this sub-study aimed to 103 
investigate the effect of vitamin B complex supplementation on cord plasma concentrations, women 104 
in the iron group were also excluded. Finally, cord blood samples were collected from 331 women.  105 
The study was conducted according to the guidelines in the Declaration of Helsinki. Ethical 106 
approval was obtained from the ethics review committee of the Xi’an Jiaotong University Health 107 
Science Center (No.2012008). All participants provided written informed consent before their 108 
participation in the study. 109 
 110 
Data collection 111 
At enrollment, sociodemographic characteristics, including age, education, occupation, household 112 
wealth status and reproductive history, were collected by face-to-face interviews using a standardised 113 
and structured questionnaire. After removal of heavy clothing and shoes, height was measured to the 114 
nearest 0.1 cm with a stadiometer and weight was measured to the nearest 0.1 kg with an electronic 115 
scale. Accordingly, BMI was calculated as weight in kilograms divided by height in meters squared 116 
The number of dispensed vitamin B complex supplements and those returned at each bimonthly 117 
antenatal check were record. Participants were also asked to report the use of FA supplements before 118 
conception and during pregnancy within one week after delivery. All the information was recorded 119 
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by township maternal and child health workers through a web-based surveillance system.  120 
 121 
Cord blood collection and laboratory analysis 122 
Cord blood samples were collected from pregnant women at delivery using 5-mL EDTA-treated 123 
vacutainer tubes and kept on 4 C. Plasma and buffy coat were separated within 24 h and stored at -124 
80 C until analysis. Plasma was analyzed within 12 months after collection by using the electro-125 
chemiluminescence assay for folate and vitamin B12 and the enzymatic assay for Hcy. The intraassay 126 
CVs for folate, vitamin B12 and Hcy were 6.7%, 3.4% and 3.0%, and the interassay CVs were 8.1%, 127 
7.0% and 7.3%, respectively.  128 
 129 
Statistical analysis 130 
The sample size in this sub-study was able to detect a 31.6% standard deviation unit difference 131 
between groups with a 2-sided type Ι error rate of 5% and 80% power. Household wealth index was 132 
constructed from an inventory of 15 household assets or facilities through principal component 133 
analysis, and this index was classified as tertiles: low (poorest), medium (middle-income) and high 134 
(richest) [20]. The compliance of vitamin B complex supplements was calculated by dividing the 135 
number of supplements consumed by the number of days from enrollment to delivery. Mean ± SDs 136 
or medians (25th, 75th percentiles) were used to describe normally or abnormally distributed 137 
continuous variables, respectively. Numbers (%) were used to describe categorical variables.  138 
All analyses were conducted based on the intention to treat principle. All biochemical indicators 139 
were log-transformed before analyses. The cluster level baseline characteristics between groups were 140 
compared by using Wilcoxon two-sample tests. To adjust for clustering effect, two-level mixed 141 
models (township to level 2 and individual to level 1) were applied to assess the individual level 142 
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differences between groups, including baseline characteristics, number of FA supplements consumed, 143 
and cord plasma concentrations of folate, vitamin B12, and Hcy. Continuous variables and categorical 144 
variables were analyzed by using linear mixed models and generalized linear mixed models, 145 
respectively. Subgroup analyses according to baseline characteristics (gestational age at enrolment, 146 
household wealth index, parity and maternal age) were further conducted. Potential interactions 147 
between baseline characteristics and vitamin B complex supplementation were evaluated by 148 
including an interaction term in models.  149 
All statistical analyses were conducted using SAS software (version 9.4; SAS Institute Inc.). Two 150 
sided P < 0.05 were considered statistically significant. 151 
 152 
Results 153 
Figure 1 shows the flow chart of this study. A total of 760 pregnant women in the Xunyi county were 154 
enrolled in the trial from January to December 2017. Of these participants, 392 were eligible for 155 
inclusion in the biomarker sub-study. Of these eligible participants, seven were lost to follow-up, 19 156 
had a spontaneous or induced abortion, one ended her pregnancy with stillbirth, and 34 refused cord 157 
blood sampling. Ultimately, cord blood samples were available for 331 women, representing 84.4% 158 
of the 392 eligible participants.  159 
Baseline characteristics were similar between the participants with or without cord blood. Among 160 
the participants with cord blood, the mean (SD) age was 26.4 (4.4) years, and 9.7% were educated 161 
beyond junior school, and 92.2% were farmers. Primiparous women made up 52.3% of the study 162 
sample. The mean gestational age at enrolment was 14.9 (4.6) and nearly one-third (29.6%) had a 163 
gestational age <12 wk. The mean (SD) height, weight and BMI at enrolment was 159.5 (4.9) cm, 164 
55.5 (7.3) kg and 21.8 (2.8) kg/m2, respectively (Supplemental Table 1). The individual level baseline 165 
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characteristics were balanced between the participants in the control group and those in the vitamin 166 
B complex group (Table 1). There were four clusters in the control group and five clusters in the 167 
vitamin B complex group. The two groups were almost identical in terms of cluster level baseline 168 
characteristics, including number of villages, area, population, number of pregnancies, per capita 169 
gross domestic product and per capita net income (Supplemental Table 2). 170 
The mean (SD) number of FA supplements consumed from three months before conception to 171 
delivery was 77 (52) in the control group and 85 (63) in the vitamin B complex group, which was 172 
similar between groups. The mean (SD) number of vitamin B complex supplements consumed from 173 
enrollment to delivery was 129 (76) in the vitamin B complex group (Table 2). The mean (SD) 174 
compliance with vitamin B complex supplementation was 69.5% (30.6%).  175 
The intracluster correlation coefficients for cord plasma concentrations of folate, vitamin B12, and 176 
Hcy were 0, 0.03, and 0.02, respectively. The effect of vitamin B complex supplementation on cord 177 
plasma concentrations is shown in Table 3. Newborns of mothers who received vitamin B complex 178 
supplements had higher cord plasma vitamin B12 concentrations (median: 218.1 pg/mL v. 183.7 179 
pg/mL, P = 0.001) and lower Hcy concentrations (median: 15.7 μmol/L v. 18.1 μmol/L, P = 0.033) 180 
than did those in the control group. No significant difference was observed between groups in cord 181 
plasma folate concentrations (P > 0.05). There was no evidence of a differential effect of the 182 
intervention by baseline characteristics (gestational age at enrolment, household wealth index, parity 183 
and maternal age) on cord plasma concentrations of vitamin B12 and Hcy (Table 4).  184 
 185 
Discussion 186 
In this cluster randomized controlled trial of vitamin B complex supplementation during pregnancy, 187 
we found that newborns born to supplemented mothers had higher cord plasma vitamin B12 188 
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concentrations and lower Hcy concentrations, indicative of improved vitamin B12 status.  189 
Vitamin B12 acts as a cofactor in the remethylation of Hcy and in the formation of succinyl-CoA 190 
[21]. Therefore, vitamin B12 deficiency can lead to accumulation of Hcy and methylmalonic acid [21]. 191 
Poor vitamin B12 status, characterized as low vitamin B12 concentrations and elevated concentrations 192 
of Hcy and methylmalonic acid, has been thought to be highly prevalent among women of 193 
childbearing age, especially in South Asia where the population is predominantly vegetarian [7-10]. 194 
There are limited data on vitamin B12 status among Chinese women. A nutrition survey in Shaanxi 195 
province of northwest China found that the vitamin B12 concentrations of women aged 10-49 years 196 
was low and nearly half of rural women were vitamin B12 deficiency [6]. Given the high rate of 197 
vitamin B12 insufficiency and the pivotal role of vitamin B12 in fetal growth and development, several 198 
clinical trials of vitamin B12 supplementation during pregnancy and early lactation have been 199 
conducted in South Asia. The results from the Matlab Trial in Bangladesh showed that the prevalence 200 
of vitamin B12 deficiency among infants aged 6 months decreased by 11% after multivitamin 201 
supplementation (containing 2.6 g/day of vitamin B12) from 14 week of gestation to 3-month 202 
postpartum [16]. In the trial in India, when supplemented with 50 g/day of vitamin B12 from <14 203 
week of gestation to 6-week postpartum, infant at 6 weeks of age had higher vitamin B12 204 
concentrations and lower Hcy and methylmalonic concentrations [17]. In another intervention study 205 
in Bangladesh, supplementation with 250 g/day of vitamin B12 throughout pregnancy and 3-month 206 
postpartum increased vitamin B12 concentrations and lowered Hcy and methylmalonic acid 207 
concentrations in both newborns and infants at 3 months of age[18]. In our trial, pregnant women <20 208 
week of gestation were allocated to receive or not to receive vitamin B complex supplements during 209 
pregnancy. The supplements used in this trial contained 2 g of vitamin B12 per tablet. Even with a 210 
low dose of vitamin B12, newborns responded to vitamin B complex supplementation with 211 
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significantly higher cord plasma vitamin B12 concentrations and lower Hcy concentrations. The 212 
variation in the dose of vitamin B12, the duration of supplementation and time point measured between 213 
studies made it difficult to compare with each other. However, all these findings suggested that taking 214 
vitamin B12-containing supplements during pregnancy is an effective way to improve neonatal or 215 
infant vitamin B12 status in populations where vitamin B12 deficiency is common.  216 
It is noteworthy that even with vitamin B complex supplementation, cord plasma vitamin B12 status 217 
in study population was poorer in comparison with those previously measured in other populations. 218 
The median cord plasma Hcy concentrations in the vitamin B complex group is much higher than the 219 
values of 6.2-11.0 μmol/L reported in Norway [22], the Netherlands [23] and Bangladesh [18]. A 220 
possible explanation for the poor vitamin B12 status among newborns was that pregnant women 221 
residing in this region are suffering from chronic malnutrition. Xunyi county is located in the southern 222 
Loess Plateau of Shaanxi Province and is one of state-level poverty-stricken counties [24]. The 223 
availability of animal products may be limited by poor natural environment and low economic level. 224 
In addition, genetic factors may also affect the vitamin B12 status of newborns. Methylene-225 
tetrahydrofolate reductase (MTHFR) is responsible for the conversion of 5,10-methylene-226 
tetrahydrofolate to 5-methyl- tetrahydrofolate, which is essential for the remethylation of Hcy [25]. 227 
The MTHFR 677CT variant results in a thermolabile enzyme that has reduced activity in the 228 
synthesis of 5-tetrahydrofolate [25]. Accordingly, individuals with the MTHFR 677T allele have 229 
higher Hcy concentrations. The frequency of the MTHFR 677T allele in Shaanxi Province was 230 
reported to be 43.3% [26], which is at a high level globally [27]. Our findings suggested that the dose 231 
of 2 g/day of vitamin B12 during pregnancy may be inadequate to ensure the acceptable vitamin B12 232 
status of Chinese newborns. Additional studies are required to further explore the optimal dose of 233 
vitamin B12. 234 
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Hyperhomocysteinemia, which refers to abnormally high homocysteine concentrations in the 235 
blood, has been considered as an independent risk factor for cardiovascular disease [28], cognitive 236 
impairment [29] and adverse pregnancy outcomes [30]. Our finding of maternal vitamin B complex 237 
supplementation during pregnancy lowering neonatal Hcy concentrations offered a potential strategy 238 
for primary prevention. To further confirm the effects of antenatal vitamin B complex 239 
supplementation on offspring’s clinical outcomes, it would be necessary to conduct a long-term 240 
follow-up of our trial. 241 
The main strength of the present study is that the design of randomized controlled trial has the 242 
ability to investigate causal association between maternal vitamin B complex supplementation and 243 
neonatal vitamin B12 status. However, our findings should be interpreted cautiously in light of some 244 
limitations. First, neither participants nor researchers were blinded. On the basis of the fact that the 245 
outcome indicators in this study were objective and the attrition rates between groups were similar 246 
(vitamin B complex group v. control group: 17.0% v. 14.2%, P = 0.444), we believed that the non-247 
blinded design has a limited impact on estimated treatment effects [31]. Second, the unit of 248 
randomization was a township rather than an individual, which might have introduced a larger random 249 
error. To adjust for clustering effect, two-level mixed models were conducted in the present study. 250 
Fortunately, both the cluster and individual level baseline characteristics were shown to be similar. 251 
Third, except for vitamin B12 and Hcy, other functional biomarkers of vitamin B12 such as 252 
methylmalonic acid and holo-transcobalamin have not been measured. Fourth, blood samples beyond 253 
the newborn period have not been collected in this sub-study. Thus, the longer-term effect of vitamin 254 
B complex supplementation on offspring’s vitamin B12 status remains unknown. 255 
In conclusion, in the cluster randomized controlled trial in rural northwest China, we found that 256 
maternal vitamin B complex supplementation during pregnancy could be effective in improving 257 
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neonatal vitamin B12 status. Our study provided valuable evidence for the development of public 258 
health policies on vitamin B12 supplementation during pregnancy.  259 
 260 
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Table 1 Baseline characteristics of pregnant women in control and vitamin B 
complex groups. 
 
Vitamin B complex group 
( n =156) 
Control group 
( n =175) 
Pa 
Age (y) 26.8  4.6 26.0  4.1 0.140 
  <25 y 59 (37.8) 82 (46.9) 0.088 
  25-29 y 63 (40.4) 66 (37.7)  
  30 y 34 (21.8) 27 (15.4)  
Education   0.975 
  Primary school or below 102 (65.4) 112 (64.0)  
  Junior school 39 (25.0) 46 (26.3)  
  Senior high school or above 15 (9.6) 17 (9.7)  
Occupation   0.930 
  Farmer 143 (91.7) 162 (92.6)  
  Others 13 (8.3) 13 (7.4)  
Household wealth index 0.1 (1.4) -0.1 (1.5) 0.477 
  Poor 46 (29.5) 60 (34.3) 0.585 
  Medium 50 (32.1) 64 (36.6)  
  Rich 60 (38.5) 51 (29.1)  
Parity 0.5  0.5  0.691 
  Primiparous 82 (52.6) 91 (52.0) 0.979 
  Multiparous 74 (47.4) 84 (48.0)  
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Gestational age at enrolment (wk) 14.7  4.8 15.1  4.4 0.777 
  <12 wk 46 (29.5) 52 (29.7) 0.554 
  12 wk 110 (70.5) 123 (70.3)  
Height (cm) 159.4  5.0 159.7  4.9 0.573 
Weight at enrolment (kg) 55.1  7.0 55.9  7.7 0.352 
BMI at enrolment (kg/m2) 21.7  2.5 21.9  2.9 0.515 
Values are means  SDs or n (%). 
aDifferences between groups were assessed by using two-level linear mixed models for 
continuous variables or two-level generalized linear mixed models for categorical variables. 
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Table 2 Number of supplements consumed in control and vitamin B complex groups. 
 
Vitamin B complex group 
( n = 156) 
Control group 
 ( n = 175) Pa 
Folic acid supplementsb 85  63 77  52 0.461 
  <60 57 (36.5) 59 (33.7) 0.799 
  60-119 62 (39.7) 82 (46.9)  
  120-179 15 (9.6) 20 (11.4)  
  180 22 (14.1) 14 (8.0)  
Vitamin B complex supplementsc 129  76 -- -- 
  <60 19 (12.2) -- -- 
  60-119 48 (30.8) --  
  120-179 42 (26.9) --  
  180 47 (30.1) --  
Values are means  SDs or n (%). 
aDifferences between groups were assessed by using two-level linear mixed model for 
continuous variable or two-level generalized linear mixed model for categorical variable. 
bFrom three months before conception to delivery. 
cFrom enrollment to delivery. 
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Table 3 Effect of vitamin B complex supplementation during pregnancy on cord 
plasma concentrations of folate, vitamin B12, and Hcy. 
 
Vitamin B complex group 
( n = 156)  
Control group 
( n = 175)  
Pa 
Plasma folate (ng/mL) 8.2 (5.9, 12.7) 7.6 (6.2, 11.3) 0.455  
Plasma vitamin B12 (pg/mL) 218.1 (159.7, 298.1) 183.7 (141.7, 229.9) 0.001 
Plasma Hcy (μmol/L) 15.7 (11.5, 22.4) 18.1 (12.9, 25.4) 0.033  
Hcy, homocysteine. 
Values are medians (25th, 75th percentiles). 
aDifferences between groups were assessed by using two-level linear mixed models. 
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Table 4 Stratified analysis of the effect of vitamin B complex supplementation on 
cord plasma concentrations of vitamin B12 and Hcy. 
 
Vitamin B complex 
group ( n = 156) 
Control group 
( n = 175) Pa 
P 
interaction 
Plasma vitamin B12 (pg/mL)     
  Gestational age at enrolment    0.293 
    <12 wk 224.5 (165.8, 287.0) 175.8 (144.0, 235.7) 0.001  
    12 wk 213.1 (159.4, 301.9) 184.6 (139.3, 227.2) 0.002  
  Household wealth index    0.842 
    Poor 216.7 (160.2, 325.5) 174.9 (133.3, 219.0) 0.006  
    Medium 212.3 (157.1, 301.9) 187.3 (142.9, 230.1) 0.011  
    Rich 224.5 (167.2, 288.8) 187.3 (148.4, 233.8) 0.044  
  Parity    0.347 
    Primiparous 232.7 (180.1, 336.4) 201.2 (149.3, 256.8) 0.012  
    Multiparous 204.7 (147.4, 273.5) 159.7 (133.7, 216.3) <0.001  
  Maternal age     0.742 
    <25 y 209.4 (160.2, 301.9) 175.2 (136.7, 233.8) 0.020  
    25-29 y 204.9 (152.5, 273.5) 188.7 (145.3, 221.7) 0.010  
    30 y 250.3 (179.6, 349.1) 178.4 (143.3, 239.7) 0.014  
Plasma Hcy (μmol/L)     
  Gestational age at enrolment    0.150 
    <12 wk 14.6 (11.2, 19.9) 18.3 (13.3, 29.1) 0.014  
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    12 wk 16.3 (11.8, 22.4) 18.1 (12.9, 24.8) 0.236  
  Household wealth index    0.146 
    Poor 15.2 (12.2, 22.3) 21.2 (16.4, 27.1) 0.008  
    Medium 15.3 (11.4, 23.3) 16.9 (13.2, 25.0) 0.211  
    Rich 16.3 (11.0, 21.5) 13.8 (10.6, 22.6) 0.935  
  Parity    0.696 
    Primiparous 15.1 (11.3, 21.5) 15.8 (11.8, 24.3) 0.147  
    Multiparous 16.3 (12.2, 22.4) 20.8 (15.2, 27.0) 0.055  
  Maternal age    0.863 
    <25 y 15.2 (12.1, 22.0) 18.5 (12.8, 27.6) 0.050  
    25-29 y 15.5 (10.6, 22.4) 16.5 (13.3, 24.8) 0.216  
    30 y 16.9 (11.5, 22.4) 20.8 (13.4, 24.1) 0.425  
Hcy, homocysteine. 
Values are medians (25th, 75th percentiles). 











Supplemental Table 1 Baseline characteristics of pregnant women with cord blood 
and those without cord blood. 
 
Cord blood collected 
( n = 331 )  
Cord blood not 
collected ( n = 61) Pa 
Age (y) 26.4  4.4 27.3  4.3 0.169  
  <25 y 141 (42.6) 19 (31.2) 0.137  
  25-29 y 129 (39.0) 28 (45.9)  
  30 y 61 (18.4) 14 (23.0)  
Education   0.053  
  Primary school or below 214 (64.7) 33 (54.1)  
  Junior school 85 (25.7) 22 (36.1)  
  Senior high school or above 32 (9.7) 6 (9.8)  
Occupation   0.270  
  Farmer 305 (92.2) 54 (88.5)  
  Others 26 (7.9) 7 (11.5)  
Household wealth index -0.001 (1.5) 0.004 (1.5) 0.562 
  Poor 113 (34.1) 18 (29.5) 0.722 
  Medium 107 (32.3) 24 (39.3)  
  Rich 111 (33.5) 19 (31.2)  
Parity 0.5  0.6  0.506 
  Primiparous 173 (52.3) 30 (49.2) 0.516 
  Multiparous 158 (47.7) 31 (50.8)  
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Gestational age at enrolment (wk) 14.9  4.6 14.3  5.5 0.355  
  <12 wk 98 (29.6) 25 (41.0) 0.070  
  12 wk 233 (70.4) 36 (59.0)  
Height (cm) 159.5  4.9 158.5  9.7 0.281  
Weight at enrolment (kg) 55.5  7.3 56.5  7.8 0.367  
BMI at enrolment (kg/m2) 21.8  2.8 22.9  5.9 0.077  
Values are means  SDs or n (%). 
aDifferences between groups were assessed by using two-level linear mixed models for continuous 
variables or two-level generalized linear mixed models for categorical variables. 
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Supplementary Table 2 Baseline characteristics of clusters in control and vitamin B complex 
groups. 
 




No. of clusters 5 4 -- 
No. of villages 12 (11, 12) 13 (9, 19) 1.000  
Area (km2) 42 (40, 74) 81 (55, 133) 0.623  
Population 17125 (16858, 19321) 19180 (11072, 31405) 1.000  
No. of pregnancies 156 (135, 187) 209 (134, 348) 0.806  
Per capita gross domestic product (RMB yuan) 54400 (50180, 102750) 63076 (32444, 73371) 0.713  
Per capita net income (RMB yuan) 10339 (9810, 11156) 9688 (9428, 11405) 0.540  
Values are medians (25th, 75th percentiles). 
aDifferences between groups were assessed by Wilcoxon two-sample test. 
 
 
 
 
